Can Cognitive Remediation in Groups Prevent Relapses?

Autor: Volker Roder, Zahra Khalesi, Daniel R. Mueller

Publikováno v: Müller, Daniel; Khalesi, Zahra; Roder, Volker (2020). Can Cognitive Remediation in Groups Prevent Relapses? Results of a 1-Year Follow-up Randomized Controlled Trial. The journal of nervous and mental disease, 208(5), pp. 362-370. Wolters Kluwer Health 10.1097/NMD.0000000000001146

International guidelines define relapse prevention for schizophrenia patients as a key therapeutic aim. However, approximately 80% to 90% of schizo- phrenia patients experience further symptom exacerbation after the first episode. The purpose of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbc99e3c4924c1482c4d864113e6033
https://doi.org/10.1097/nmd.0000000000001146

S39. THE IMPACT OF THE GROUP FACTOR ON OUTCOME IN GROUP THERAPY: FINAL RESULTS OF RCT INCLUDING 127 SCHIZOPHRENIA OUTPATIENTS

Autor: Conny Steichen, Daniel R. Mueller, Kristin Schaller, Volker Roder

Publikováno v: Schizophrenia Bulletin
Mueller, Daniel; Steichen, Conny; Schaller, Kristin; Roder, Volker (2020). S39. The impact of the group factor on outcome in group therapy: final results of RCT including 127 schizophrenia outpatients. Schizophrenia bulletin, 46(Suppl. 1), pp. 46-47. Oxford University Press 10.1093/schbul/sbaa031.105

Background Today, some evidence-based group therapy approaches focusing different treatment goals are available for the treatment of schizophrenia patients, e.g. psychoeducation, social skills training, CBTp or cognitive remediation. However, only fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe85e992b34fec986a8fd4abdbf01d37
https://doi.org/10.1093/schbul/sbaa031.105

101. Does Cognitive Remediation Therapy Prevent Relapses in Stabilized Schizophrenia Outpatients? A 1-Year RCT Follow-Up Study

Autor: Daniel R. Mueller, Volker Roder

Background: Relapses do not only add psychological burden to the individuals, their friends and families, but also are costly to the government and the health-care system. Thus, relapse prevention is a major concern and goes along with the primary go

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ebe14a7bf5f65a85f1397080a0bbbc4
https://europepmc.org/articles/PMC5475597/

Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?

Autor: Valentin Benzing, Volker Roder, Clelia I. Castiglione, Zahra Khalesi, Daniel R. Mueller

Negative symptoms often inhibit the social integration of people suffering from schizophrenia. Reducing severe negative symptoms (SNS) in a clinically relevant way is a major unmet need. The aim of this study was to inves- tigate whether Integrated N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56ddffc202649c9da7ba4f9d017c50c1

INT-Integrated Neurocognitive Therapy for Schizophrenia Patients

Autor: Volker Roder, Daniel R. Müller

This book contains concrete and step by step information with many practical examples. It is in line with the most actual international empirical findings about schizophrenia and contains the most updated therapy approach being available currently. T